cncpt-artikel_lb_atf
Nivolumab monotherapy is an effective treatment option for recurrent malignant mesothelioma
The Phase 3 study CONFIRM presented at WCLC 2020 show that nivolumab monotherapy is an effective treatment option for recurrent malignant mesothelioma.



